ArticleCancer discovery2024

CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool.

Paulien Kaptein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.